These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 16594594)

  • 1. A combination chemotherapy protocol with dose intensification and autologous bone marrow transplant (VELCAP-HDC) for canine lymphoma.
    Frimberger AE; Moore AS; Rassnick KM; Cotter SM; O'Sullivan JL; Quesenberry PJ
    J Vet Intern Med; 2006; 20(2):355-64. PubMed ID: 16594594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thirteen-week dose-intensifying simultaneous combination chemotherapy protocol for malignant lymphoma in dogs.
    Zenker I; Meichner K; Steinle K; Kessler M; Hirschberger J
    Vet Rec; 2010 Nov; 167(19):744-8. PubMed ID: 21257510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A combination chemotherapy protocol (VELCAP-L) for dogs with lymphoma.
    Zemann BI; Moore AS; Rand WM; Mason G; Ruslander DM; Frimberger AE; Wood CA; L'Heureux DA; Gliatto J; Cotter SM
    J Vet Intern Med; 1998; 12(6):465-70. PubMed ID: 9857340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of dogs with lymphoma using a 12-week, maintenance-free combination chemotherapy protocol.
    Simon D; Nolte I; Eberle N; Abbrederis N; Killich M; Hirschberger J
    J Vet Intern Med; 2006; 20(4):948-54. PubMed ID: 16955821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapy-induced neutropenia is associated with prolonged remission duration and survival time in canine lymphoma.
    Wang SL; Lee JJ; Liao AT
    Vet J; 2015 Jul; 205(1):69-73. PubMed ID: 26004824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a discontinuous treatment protocol (VELCAP-S) for canine lymphoma.
    Moore AS; Cotter SM; Rand WM; Wood CA; Williams LE; London CA; Frimberger AE; L'Heureux DA
    J Vet Intern Med; 2001; 15(4):348-54. PubMed ID: 11467592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of a high-dose chemotherapy protocol with no maintenance therapy for dogs with lymphoma.
    Chun R; Garrett LD; Vail DM
    J Vet Intern Med; 2000; 14(2):120-4. PubMed ID: 10772481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the Tolerability of Combination Chemotherapy with Mitoxantrone and Dacarbazine in Dogs with Lymphoma.
    Intile JL; Rassnick KM; Al-Sarraf R; Chretin JD
    J Am Anim Hosp Assoc; 2019; 55(2):101-109. PubMed ID: 30653362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of asparaginase on a combination chemotherapy protocol for canine multicentric lymphoma.
    Jeffreys AB; Knapp DW; Carlton WW; Thomas RM; Bonney PL; Degortari A; Lucroy MD
    J Am Anim Hosp Assoc; 2005; 41(4):221-6. PubMed ID: 15995158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase I dose escalation of single-agent vinblastine in dogs.
    Bailey DB; Rassnick KM; Kristal O; Chretin JD; Balkman CE
    J Vet Intern Med; 2008; 22(6):1397-402. PubMed ID: 19000250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and toxicity of carboplatin and cytarabine chemotherapy for dogs with relapsed or refractory lymphoma (2000-2013).
    Gillem J; Giuffrida M; Krick E
    Vet Comp Oncol; 2017 Jun; 15(2):400-410. PubMed ID: 26463827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of COAP and UW-19 protocols for dogs with multicentric lymphoma.
    Hosoya K; Kisseberth WC; Lord LK; Alvarez FJ; Lara-Garcia A; Kosarek CE; London CA; Couto CG
    J Vet Intern Med; 2007; 21(6):1355-63. PubMed ID: 18196747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a 6-month chemotherapy protocol with no maintenance therapy for dogs with lymphoma.
    Garrett LD; Thamm DH; Chun R; Dudley R; Vail DM
    J Vet Intern Med; 2002; 16(6):704-9. PubMed ID: 12465768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of factors associated with second remission in dogs with lymphoma undergoing retreatment with a cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy protocol: 95 cases (2000-2007).
    Flory AB; Rassnick KM; Erb HN; Garrett LD; Northrup NC; Selting KA; Phillips BS; Locke JE; Chretin JD
    J Am Vet Med Assoc; 2011 Feb; 238(4):501-6. PubMed ID: 21320021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autologous marrow transplantation as consolidation therapy for canine lymphoma: efficacy and toxicity of various regimens of total body irradiation.
    Deeg HJ; Appelbaum FR; Weiden PL; Hackman RC; Graham TC; Storb RC
    Am J Vet Res; 1985 Sep; 46(9):2016-8. PubMed ID: 3901841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclophosphamide, carmustine, and etoposide with autologous bone marrow transplantation in refractory Hodgkin's disease and non-Hodgkin's lymphoma: a dose-finding study.
    Wheeler C; Antin JH; Churchill WH; Come SE; Smith BR; Bubley GJ; Rosenthal DS; Rappaport JM; Ault KA; Schnipper LE
    J Clin Oncol; 1990 Apr; 8(4):648-56. PubMed ID: 2313334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequential low-dose rate half-body irradiation and chemotherapy for the treatment of canine multicentric lymphoma.
    Lurie DM; Gordon IK; Théon AP; Rodriguez CO; Suter SE; Kent MS
    J Vet Intern Med; 2009; 23(5):1064-70. PubMed ID: 19627472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carmustine, Ara C, cyclophosphamide and etoposide with autologous bone marrow transplantation in relapsed or refractory lymphoma: a dose-finding study.
    Snyder MJ; Johnson DB; Daly MB; Giguere JK; Harman GH; Harden EA; Johnson RA; Leff RS; Mercier RJ; Messerschmidt GL
    Bone Marrow Transplant; 1994 Oct; 14(4):595-600. PubMed ID: 7858534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of chemotherapeutic dose intensity and hematologic toxicity on first remission duration in dogs with lymphoma treated with a chemoradiotherapy protocol.
    Vaughan A; Johnson JL; Williams LE
    J Vet Intern Med; 2007; 21(6):1332-9. PubMed ID: 18196744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of 3 protocols for treatment after induction of remission in dogs with lymphoma.
    Rassnick KM; McEntee MC; Erb HN; Burke BP; Balkman CE; Flory AB; Kiselow MA; Autio K; Gieger TL
    J Vet Intern Med; 2007; 21(6):1364-73. PubMed ID: 18196748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.